421 related articles for article (PubMed ID: 26221017)
1. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
[TBL] [Abstract][Full Text] [Related]
3. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
[TBL] [Abstract][Full Text] [Related]
4. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of MCB3681 against Clostridium difficile strains.
Rashid MU; Dalhoff A; Weintraub A; Nord CE
Anaerobe; 2014 Aug; 28():216-9. PubMed ID: 25016084
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin.
Knight DR; Riley TV
J Antimicrob Chemother; 2016 Aug; 71(8):2213-7. PubMed ID: 27130808
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
Lachowicz D; Pituch H; Obuch-Woszczatyński P
Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain.
Reigadas E; Alcalá L; Marín M; Pelaéz T; Martin A; Iglesias C; Bouza E
J Antimicrob Chemother; 2015 Aug; 70(8):2311-5. PubMed ID: 25876881
[TBL] [Abstract][Full Text] [Related]
9. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
Freeman J; Vernon J; Pilling S; Morris K; Nicolson S; Shearman S; Clark E; Palacios-Fabrega JA; Wilcox M;
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507
[TBL] [Abstract][Full Text] [Related]
10. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes.
Freeman J; Vernon J; Morris K; Nicholson S; Todhunter S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2015 Mar; 21(3):248.e9-248.e16. PubMed ID: 25701178
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment.
Tian TT; Zhao JH; Yang J; Qiang CX; Li ZR; Chen J; Xu KY; Ciu QQ; Li RX
PLoS One; 2016; 11(3):e0151964. PubMed ID: 27011211
[TBL] [Abstract][Full Text] [Related]
12. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
Snydman DR; McDermott LA; Jacobus NV; Thorpe C; Stone S; Jenkins SG; Goldstein EJ; Patel R; Forbes BA; Mirrett S; Johnson S; Gerding DN
Antimicrob Agents Chemother; 2015 Oct; 59(10):6437-43. PubMed ID: 26239985
[TBL] [Abstract][Full Text] [Related]
13. PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015.
Karlowsky JA; Adam HJ; Kosowan T; Baxter MR; Nichol KA; Laing NM; Golding G; Zhanel GG
Diagn Microbiol Infect Dis; 2018 Jun; 91(2):105-111. PubMed ID: 29456070
[TBL] [Abstract][Full Text] [Related]
14. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
Kim J; Kang JO; Pai H; Choi TY
Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.
Gerding DN; Hecht DW; Louie T; Nord CE; Talbot GH; Cornely OA; Buitrago M; Best E; Sambol S; Osmolski JR; Kracker H; Locher HH; Charef P; Wilcox M
J Antimicrob Chemother; 2016 Jan; 71(1):213-9. PubMed ID: 26433782
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
[TBL] [Abstract][Full Text] [Related]
17. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
[TBL] [Abstract][Full Text] [Related]
18. Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption.
Seo MR; Kim B; Kim J; Pai H
Int J Antimicrob Agents; 2019 Aug; 54(2):154-158. PubMed ID: 31173866
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
Lim SC; Androga GO; Knight DR; Moono P; Foster NF; Riley TV
Int J Antimicrob Agents; 2018 Sep; 52(3):411-415. PubMed ID: 29802886
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
